Natalizumab blokerer interaktionen af α4β7 integrinet med det mukosale addressin celleadhæsionsmolekyle- 1 (MadCAM- 1).
Natalizumab blocca l’ interazione dell’ integrina α 4β 7 con MadCAM-1 (mucosal adressin cell adhesion molecole-1).